In hepatocellular carcinoma, endothelial transdifferentiation is a major pathogenic event and stabilin-2 could accelerate endothelial-tumor cell adhesive interactions and microvascular invasion. The gene discussed is STAB2; the disease is hepatocellular carcinoma.